Plastistrength® 551 - SDS
Plastistrength® 551 - SDS
Plastistrength® 551 - SDS
PLASTISTRENGTH® 551 NA
Company
Arkema Inc.
900 First Avenue
King of Prussia, Pennsylvania 19406
Emergency Information
Product Information
2. HAZARDS IDENTIFICATION
Emergency Overview
Color: white
Physical state: solid
Form: powder
Odor: none
GHS-Labelling
Hazard statements:
This material is considered hazardous under the OSHA Hazard Communication Standard criteria, based on
hazard(s) not otherwise classified.
Page 1/14
PLASTISTRENGTH® 551 NA
Supplemental information:
Other:
Handle in accordance with good industrial hygiene and safety practice. (powder) Mechanical irritation effects
from dust exposure are possible at ambient temperature. This product may release fume and/or vapor of variable
composition depending on processing time and temperature.
3. COMPOSITION/INFORMATION ON INGREDIENTS
*The specific chemical identity is withheld because it is trade secret information of Arkema Inc.
Page 2/14
PLASTISTRENGTH® 551 NA
**For the full text of the H-Statements mentioned in this Section, see Section 16.
Inhalation:
If inhaled, remove victim to fresh air.
Skin:
In case of contact, immediately flush skin with plenty of water. If molten polymer gets on the skin, cool rapidly with
cold water. Do not peel solidified product off the skin. Obtain medical treatment for thermal burns. Remove material
from clothing. Wash clothing before reuse. Thoroughly clean shoes before reuse.
Eyes:
Immediately flush eye(s) with plenty of water. Obtain medical treatment for thermal burns.
Ingestion:
If swallowed, DO NOT induce vomiting. Get medical attention. Never give anything by mouth to an unconscious
person.
For most important symptoms and effects (acute and delayed), see Section 2 (Hazard Statements and Supplemental
Information if applicable) and Section 11 (Toxicology Information) of this SDS.
4.3. Indication of immediate medical attention and special treatment needed, if necessary:
Unless otherwise noted in Notes to Physician, no specific treatment noted; treat symptomatically.
5. FIREFIGHTING MEASURES
Protective equipment:
Fire fighters and others who may be exposed to products of combustion should wear full fire fighting turn out gear
(full Bunker Gear) and self-contained breathing apparatus (pressure demand / NIOSH approved or equivalent).
Page 3/14
PLASTISTRENGTH® 551 NA
Dust clouds generated during handling and/or storage can form explosive mixtures with air. Dust explosion
characteristics vary with the particle size, particle shape, moisture content, contaminants, and other variables.
Note: Check that all equipment is properly grounded and installed to satisfy electrical classification requirements. As
with any dry material, pouring this material or allowing it to free-fall or to be conveyed through chutes or pipes can
accumulate and generate electrostatic sparks, potentially causing ignition of the material itself, or of any flammable
materials which may come into contact with the material or its container.
When burned, the following hazardous products of combustion can occur:
Carbon oxides
Hazardous organic compounds
sulfur oxides
Protective equipment:
Appropriate personal protective equipment is set forth in Section 8.
Handling
Page 4/14
PLASTISTRENGTH® 551 NA
Storage
US. OSHA Table Z-1 Limits for Air Contaminants (29 CFR 1910.1000)
US. OSHA Table Z-1 Limits for Air Contaminants (29 CFR 1910.1000)
Page 5/14
PLASTISTRENGTH® 551 NA
Only those components with exposure limits are printed in this section. Limits with skin contact designation above have skin contact
effect. Air sampling alone is insufficient to accurately quantitate exposure. Measures to prevent significant cutaneous absorption
may be required. Limits with a sensitizer designation above mean that exposure to this material may cause allergic reactions.
Engineering controls:
Investigate engineering techniques to reduce exposures below airborne exposure limits or to otherwise reduce
exposures. Provide ventilation if necessary to minimize exposures or to control exposure levels to below
airborne exposure limits (if applicable see above).If practical, use local mechanical exhaust ventilation at
sources of air contamination such as open process equipment.
Check that all dust control equipment such as local exhaust ventilation, material transport systems, and air-
material separation devices involved in handling this product contain explosion relief vents or an explosion
suppression system or an oxygen-deficient environment.Isolation devices may be appropriate to prevent
propagation from one unit to another.Ensure that dust-handling systems are designed in a manner to prevent
the escape of dust into the work area (i.e., there is no leakage from the equipment).Consult ACGIH ventilation
manual, NFPA Standard 91 and NFPA Standard 654 for design of exhaust system and safe handling.
Respiratory protection:
Avoid breathing dust. Avoid breathing processing fumes or vapors. Where airborne exposure is likely or
airborne exposure limits are exceeded (if applicable, see above), use NIOSH approved respiratory protection
equipment appropriate to the material and/or its components and substances released during processing.
Consult respirator manufacturer to determine appropriate type equipment for a given application. Observe
respirator use limitations specified by NIOSH or the manufacturer. For emergency and other conditions where
there may be a potential for significant exposure or where exposure limit may be significantly exceeded, use an
approved full face positive-pressure, self-contained breathing apparatus or positive-pressure airline with
auxiliary self-contained air supply. Respiratory protection programs must comply with 29 CFR § 1910.134.
Skin protection:
Processing of this product releases vapors or fumes which may cause skin irritation. Minimize skin
contamination by following good industrial hygiene practice. Wearing protective gloves is recommended. Wash
hands and contaminated skin thoroughly after contact with processing fumes or vapors. Wash thoroughly after
handling.
Page 6/14
PLASTISTRENGTH® 551 NA
Eye protection:
Use good industrial practice to avoid eye contact. Processing of this product releases vapors or fumes which
may cause eye irritation. Where eye contact may be likely, wear chemical goggles and have eye flushing
equipment available.
Color: white
Form: powder
Odor: none
Page 7/14
PLASTISTRENGTH® 551 NA
Stability:
The product is stable under normal handling and storage conditions.
Hazardous reactions:
Hazardous polymerization does not occur.
Materials to avoid:
Strong bases
Reducing agents
Acute toxicity
Oral:
Acute toxicity estimate > 5,000 mg/kg.
Eye Irritation:
Causes mild eye irritation. (rabbit) (data for a similar material)
Other information
The information presented is from representative materials in this chemical class. The results may vary
depending on the test substance.
Effects due to processing releases or residual monomer:
Possible cross sensitization with other acrylates and methacrylates.
Acute toxicity
Page 8/14
PLASTISTRENGTH® 551 NA
Oral:
Harmful if swallowed. (rat) LD50 = 1,200 mg/kg.
Dermal:
No deaths occurred. (rabbit) LD0 > 2,000 mg/kg. (data for a similar material)
Skin Irritation:
Causes skin irritation. (rabbit) (24 h)
Eye Irritation:
Causes serious eye damage. (rabbit)
Skin Sensitization:
Not a sensitizer. LLNA: Local Lymph Node Assay. (mouse) No skin allergy was observed
Not a sensitizer. Guinea pig maximization test. No skin allergy was observed
Carcinogenicity
Chronic dietary administration to rat / No increase in tumor incidence was reported.
Genotoxicity
Assessment in Vitro:
No genetic changes were observed in laboratory tests using: bacteria, animal cells
Genotoxicity
Assessment in Vivo:
No genetic changes were observed in laboratory tests using: rat, mice
Other information
The information presented is from representative materials in this chemical class. The results may vary
depending on the test substance.
Biodegradation:
Readily biodegradable. (28 d) biodegradation 95 %
Page 9/14
PLASTISTRENGTH® 551 NA
Additional Information:
The information presented is from representative materials in this chemical class. The results may vary
depending on the test substance.
Biodegradation:
Readily biodegradable. (28 d) biodegradation 80 %
Additional Information:
The information presented is from representative materials in this chemical class. The results may vary
depending on the test substance.
Ecotoxicology
Data on this material and/or its components are summarized below.
The information presented is from representative materials in this chemical class. The results may vary
depending on the test substance.
Aquatic invertebrates:
Toxic. Ceriodaphnia dubia 48 h LC50 = 5.55 mg/l
Algae:
Practically nontoxic. Desmodesmus subspicatus (green algae) 72 h EC50 > 120 mg/l
Microorganisms:
Respiration inhibition of activated sludge / Activated sludge 3 h EC50 = 135 mg/l
The information presented is from representative materials with this Chemical Abstract Service (CAS) Registry
number. The results vary depending on the size and composition of the test substance.
Aquatic invertebrates:
Very toxic. Daphnia magna (Water flea) 48 h EL50 = 0.23 mg/l
Algae:
Very toxic. Selenastrum capricornutum 72 h ErL50 = 0.44 mg/l
Page 10/14
PLASTISTRENGTH® 551 NA
Waste disposal:
Where possible recycling is preferred to disposal or incineration. If recycling is not an option, incinerate or dispose of
in accordance with federal, state, and local regulations. Pigmented, filled and/or solvent laden product may require
special disposal practices in accordance with federal, state and local regulations. Consult a regulatory specialist to
determine appropriate state or local reporting requirements, for assistance in waste characterization and/or
hazardous waste disposal and other requirements listed in pertinent environmental permits. Note: Chemical
additions to, processing of, or otherwise altering this material may make this waste management information
incomplete, inaccurate, or otherwise inappropriate. Furthermore, state and local waste disposal requirements may
be more restrictive or otherwise different from federal laws and regulations.
US. Toxic Substances Control Act TSCA The components of this product are all on
the TSCA Inventory.
Canadian Domestic Substances List (DSL) DSL All components of this product are on the
Canadian DSL
Japan. ENCS - Existing and New Chemical ENCS (JP) Does not conform
Substances Inventory
Japan. ISHL - Inventory of Chemical Substances ISHL (JP) Does not conform
Page 11/14
PLASTISTRENGTH® 551 NA
The components in this product are either not CERCLA regulated, regulated but present in negligible
concentrations, or regulated with no assigned reportable quantity.
California Prop. 65
This product does not contain any chemicals known to the State of California to cause cancer, birth
defects, or any other reproductive defects.
Miscellaneous:
Other information: Refer to National Fire Protection Association (NFPA) Code 654,
Standard for the Prevention of Fire and Dust Explosions from the
Manufacturing, Processing, and Handling of Combustible Particulate
Solids, for safe handling.
Latest Revision(s):
Page 12/14
PLASTISTRENGTH® 551 NA
The statements, technical information and recommendations contained herein are believed to be accurate as of the date hereof.
Since the conditions and methods of use of the product and of the information referred to herein are beyond our control, ARKEMA
expressly disclaims any and all liability as to any results obtained or arising from any use of the product or reliance on such
information; NO WARRANTY OF FITNESS FOR ANY PARTICULAR PURPOSE, WARRANTY OF MERCHANTABILITY OR ANY
OTHER WARRANTY, EXPRESSED OR IMPLIED, IS MADE CONCERNING THE GOODS DESCRIBED OR THE INFORMATION
PROVIDED HEREIN. The information provided herein relates only to the specific product designated and may not be applicable
when such product is used in combination with other materials or in any process. The user should thoroughly test any application
before commercialization. Nothing contained herein constitutes a license to practice under any patent and it should not be
construed as an inducement to infringe any patent and the user is advised to take appropriate steps to be sure that any proposed
use of the product will not result in patent infringement. See SDS for Health & Safety Considerations.
Arkema has implemented a Medical Policy regarding the use of Arkema products in Medical Devices applications that are in contact
with the body or circulating bodily fluids (http://www.arkema.com/en/social-responsibility/responsible-product-management/medical-
device-policy/index.html) Arkema has designated Medical grades to be used for such Medical Device applications. Products that
have not been designated as Medical grades are not authorized by Arkema for use in Medical Device applications that are in
contact with the body or circulating bodily fluids. In addition, Arkema strictly prohibits the use of any Arkema products in Medical
Device applications that are implanted in the body or in contact with bodily fluids or tissues for greater than 30 days. The Arkema
trademarks and the Arkema name shall not be used in conjunction with customers' medical devices, including without limitation,
permanent or temporary implantable devices , and customers shall not represent to anyone else, that Arkema allows, endorses or
permits the use of Arkema products in such medical devices.
It is the sole responsibility of the manufacturer of the medical device to determine the suitability (including biocompatibility) of all raw
materials, products and components, including any medical grade Arkema products, in order to ensure that the final end-use
product is safe for its end use; performs or functions as intended; and complies with all applicable legal and regulatory requirements
(FDA or other national drug agencies) It is the sole responsibility of the manufacturer of the medical device to conduct all necessary
tests and inspections and to evaluate the medical device under actual end-use requirements and to adequately advise and warn
purchasers, users, and/or learned intermediaries (such as physicians) of pertinent risks and fulfill any postmarket surveillance
obligations. Any decision regarding the appropriateness of a particular Arkema material in a particular medical device should be
based on the judgment of the manufacturer, seller, the competent authority, and the treating physician.
Page 13/14